Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-Amplifying RNA Approach for Protein Replacement Therapy
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12884-12884
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

mRNA in the Context of Protein Replacement Therapy
Theofanis Vavilis, Εleni Stamoula, Alexandra Ainatzoglou, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 166-166
Open Access | Times Cited: 64
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 59
mRNA therapies: Pioneering a new era in rare genetic disease treatment
Guobo Shen, Jian Liu, Hanmei Yang, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 696-721
Closed Access | Times Cited: 14
Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency
Joshua E. McGee, Jack R. Kirsch, Devin Kenney, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 13
Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review
Shiza Malik, Muhammad Asghar, Yasir Waheed
Vaccine X (2024) Vol. 17, pp. 100452-100452
Open Access | Times Cited: 7
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2111-2129
Open Access | Times Cited: 6
Effect of in vitro transcription conditions on yield of high quality messenger and self-amplifying RNA
Petya Popova, Melissa A. Lagace, George Tang, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 198, pp. 114247-114247
Open Access | Times Cited: 5
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines
Namratha Turuvekere Vittala Murthy, Kseniia Vlasova, Jonas Renner, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115305-115305
Closed Access | Times Cited: 5
Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity
Nuthan Vikas Bathula, Josh J. Friesen, Irafasha C. Casmil, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 28-38
Open Access | Times Cited: 4
Targeting pseudoknots with Cas13b inhibits porcine epidemic diarrhoea virus replication
Hee-Jeong Han, Daseuli Yu, Jeonghye Yu, et al.
Journal of General Virology (2025) Vol. 106, Iss. 2
Closed Access
Targeted suppression of type 1 interferon signaling during RNA delivery enhances vaccine-elicited immunity
Byungji Kim, Ryan R. Hosn, Tanaka Remba, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Respiratory Syncytial Virus Infection: Treatments and Clinical Management
Shiza Malik, Tahir Ahmad, Khalid Muhammad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 491-491
Open Access | Times Cited: 11
Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA
Joshua E. McGee, Jack R. Kirsch, Devin Kenney, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
Efficient in vitro and in vivo transfection of self-amplifying mRNA with linear poly(propylenimine) and poly(ethylenimine-propylenimine) random copolymers as non-viral carriers
Lisa Opsomer, Somdeb Jana, Ine Mertens, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 16, pp. 3927-3946
Open Access | Times Cited: 3
Advances in Zika virus vaccines and therapeutics: A systematic review
Shiza Malik, Khalid Muhammad, Omar Ahsan, et al.
Asian Pacific Journal of Tropical Medicine (2024) Vol. 17, Iss. 3, pp. 97-109
Open Access | Times Cited: 3
Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
Ziqi Cheng, Junfeng Ma, Chenyan Zhao
Vaccines (2024) Vol. 12, Iss. 12, pp. 1382-1382
Open Access | Times Cited: 2
Evaluation of self-amplifying mRNA platform for protein expression and genetic stability: Implication for mRNA therapies
Swarda Deo, Kaushik Desai, Aishwarya Patare, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 680, pp. 108-118
Closed Access | Times Cited: 6
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?
Matteo Puccetti, Aurélie Schoubben, Stefano Giovagnoli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2218-2218
Open Access | Times Cited: 5
Design, evaluation, and immune simulation of potentially universal multi-epitope mpox vaccine candidate: focus on DNA vaccine
Nino Rcheulishvili, Jiawei Mao, Dimitri Papukashvili, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 5
Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses
Alexandro Guterres, Paulo Niemeyer Filho, Vivaldo Moura‐Neto
Vaccines (2024) Vol. 12, Iss. 1, pp. 61-61
Open Access | Times Cited: 1
Position-Specific Nucleoside Sugar Modifications in mRNA ORF: Enhancing Translational Function through Complete Chemical Synthesis of mRNA
Hiroto Iwai, Yasuaki Kimura, Masakazu Honma, et al.
(2024)
Open Access | Times Cited: 1
Promising RNA-based therapies for Viral infections, Genetic Disorders and Cancer
Dickson Achimugu Musa, Mohammed Olumide Raji, Akeem Babatunde Sikiru, et al.
Academia molecular biology and genomics. (2024) Vol. 1, Iss. 1
Closed Access | Times Cited: 1
The Impact of COVID-19 on RNA Therapeutics: A Surge in Lipid Nanoparticles and Alternative Delivery Systems
Nargish Parvin, Tapas Kumar Mandal, Sang‐Woo Joo
Pharmaceutics (2024) Vol. 16, Iss. 11, pp. 1366-1366
Open Access | Times Cited: 1
Emerging perspectives on RNA virus-mediated infections: from pathogenesis to therapeutic interventions
Pratik Mohanty, Poojarani Panda, Rakesh Kumar Acharya, et al.
World Journal of Virology (2023) Vol. 12, Iss. 5, pp. 242-255
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top